Next Article in Journal
Special Issue: The Actin-Myosin Interaction in Muscle: Background and Overview
Previous Article in Journal
Antimicrobial Peptides as Anti-Infective Agents in Pre-Post-Antibiotic Era?
Open AccessCommunication

HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma

1
Division of Molecular and Genetic Medicine, Graduate School of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan
2
Division of Surgical Oncology, Department of Surgery, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(22), 5714; https://doi.org/10.3390/ijms20225714
Received: 17 October 2019 / Revised: 12 November 2019 / Accepted: 13 November 2019 / Published: 14 November 2019
(This article belongs to the Section Molecular Biology)
Unconventional prefoldin RNA polymerase II subunit 5 interactor (URI1) has emerged as an oncogenic driver in hepatocellular carcinoma (HCC). Although the hepatitis B virus (HBV) represents the most common etiology of HCC worldwide, it is unknown whether URI1 plays a role in HBV-related HCC (HCC-B). In the present study, we investigated URI1 expression and its underlying mechanism in HCC-B tissues and cell lines. URI1 gene-promoter activity was determined by a luciferase assay. Human HCC-B samples were used for a chromatin immunoprecipitation assay. We found that c-MYC induced URI1 expression and activated the URI1 promoter through the E-box in the promoter region while the HBx protein significantly enhanced it. The positivity of URI1 expression was significantly higher in HCC-B tumor tissues than in non-HBV-related HCC tumor tissues, suggesting that a specific mechanism underlies URI1 expression in HCC-B. In tumor tissues from HCC-B patients, a significantly higher level of c-MYC was recruited to the E-box than in non-tumor tissues. These results suggest that HBx and c-MYC are involved in URI1 expression in HCC-B. URI1 expression may play important roles in the development and progression of HCC-B because HBx and c-MYC are well-known oncogenic factors in the virus and host, respectively. View Full-Text
Keywords: URI1; HBx; c-MYC; HBV-related hepatocellular carcinoma; E-box URI1; HBx; c-MYC; HBV-related hepatocellular carcinoma; E-box
Show Figures

Graphical abstract

MDPI and ACS Style

Tsuchiya, H.; Amisaki, M.; Takenaga, A.; Honjo, S.; Fujiwara, Y.; Shiota, G. HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma. Int. J. Mol. Sci. 2019, 20, 5714. https://doi.org/10.3390/ijms20225714

AMA Style

Tsuchiya H, Amisaki M, Takenaga A, Honjo S, Fujiwara Y, Shiota G. HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2019; 20(22):5714. https://doi.org/10.3390/ijms20225714

Chicago/Turabian Style

Tsuchiya, Hiroyuki; Amisaki, Masataka; Takenaga, Ai; Honjo, Soichiro; Fujiwara, Yoshiyuki; Shiota, Goshi. 2019. "HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma" Int. J. Mol. Sci. 20, no. 22: 5714. https://doi.org/10.3390/ijms20225714

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop